Or Kles - 13 Jul 2023 Form 4 Insider Report for My Size, Inc. (MYSZ)

Role
Chief Financial Officer
Signature
/s/ Or Kles
Issuer symbol
MYSZ
Transactions as of
13 Jul 2023
Transactions value $
$0
Form type
4
Filing time
17 Jul 2023, 17:04:53 UTC
Previous filing
03 Oct 2022
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYSZ Option to purchase Common Stock (right to buy) Disposed to Issuer -560 -100% 0 13 Jul 2023 Common Stock, $.001 par value per share 560 $26 Direct F1, F2
transaction MYSZ Option to purchase Common Stock (right to buy) Award +560 560 13 Jul 2023 Common Stock, $.001 par value per share 560 $1.09 Direct F1, F2
transaction MYSZ Option to purchase Common Stock (right to buy) Disposed to Issuer -5,200 -100% 0 13 Jul 2023 Common Stock, $.001 par value per share 5,200 $26 Direct F1, F2
transaction MYSZ Option to purchase Common Stock (right to buy) Award +5,200 5,200 13 Jul 2023 Common Stock, $.001 par value per share 5,200 $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
F2 Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged.

Remarks:

On December 8, 2022, the Company implemented a 1-for-25 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.